Reprise Biomedical

Reprise Biomedical is developing technology to treat wounds and strengthen soft tissue. The current methods to remove cells like immersion decellularization are limited to thin tissues. Using their perfusion decellularization technology, Reprise has found solutions to effectively decellularize whole porcine organs while preserving the collagen scaffold that retains strength allowing cellular integration. Depending on the application, the scaffold can then be trimmed or cut and applied to various treatments from deep and tunneling wounds, diabetic foot ulcers and other advanced wound conditions.

Jobs: